PDF) ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
European Crohn´s and Colitis Organisation - ECCO - Published ECCO Guidelines
PDF) ECCO-EFCCA Patient Guidelines on Ulcerative Colitis (UC)
PDF) ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
VSL#3® for Ulcerative Colitis (UC), Pouchitis, and Irritable Bowel Syndrome (IBS) for HCPs
ECCO E-Guide
Frontiers | A Personalized Approach to Managing Patients With an Ileal Pouch-Anal Anastomosis | Medicine
European Crohn´s and Colitis Organisation - ECCO - Published ECCO Guidelines
VSL#3 - Posts | Facebook
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis | Gut
European Crohn´s and Colitis Organisation - ECCO - P510 Dose escalation of subcutaneous vedolizumab in patients with ulcerative colitis: A post hoc analysis of the VISIBLE trial data
European Crohn´s and Colitis Organisation - ECCO - P510 Dose escalation of subcutaneous vedolizumab in patients with ulcerative colitis: A post hoc analysis of the VISIBLE trial data
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease | Calafiore | Journal of Gastroenterology and Hepatology Research
Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases
The VSL#3® Difference in Irritable Bowel Syndrome (IBS)
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults | Gut
View of The role of antibiotics and probiotics in pouchitis | Annals of Gastroenterology
European Crohn´s and Colitis Organisation - ECCO - ECCO Guidelines